Lupus skin study reveals why patients skip meds
NCT ID NCT06506214
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 202 adults with cutaneous lupus to see how well they follow their treatment plans and how satisfied they are with their care. Researchers used questionnaires to measure adherence, beliefs about medicine, anxiety, depression, and quality of life. The goal is to understand what factors—like fear of side effects or the doctor-patient relationship—affect treatment adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP Hôpital Saint-Louis
Paris, 75010, France
-
Hôpital Tenon
Paris, 75020, France
-
University Hospital Montpellier
Montpellier, 34090, France
-
University Hospital Toulouse
Toulouse, 31400, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a skin biopsy tell your doctor which treatment will work?
- Scientists launch hunt for clues in autoimmune skin diseases
- New hope for lupus skin flares? drug shows promise in early trial
- Lupus patients needed for Long-Term study
- New registry aims to unlock secrets of autoimmune disease in pregnancy
- New antibody drug takes aim at autoimmune diseases